1026134-63-3 Usage
General Description
Nelonicline is a pharmaceutical compound that has shown potential as a treatment for cognitive impairments associated with various neurological and psychiatric conditions. It acts as a selective agonist for the alpha-7 nicotinic acetylcholine receptor, which is involved in regulating neurotransmitter release and enhancing cognitive function. Studies have indicated that nelonicline may improve symptoms in patients with schizophrenia, Alzheimer's disease, and attention-deficit hyperactivity disorder, making it a promising candidate for further clinical development. Additionally, nelonicline has demonstrated a favorable safety profile in early trials, further supporting its potential as a therapeutic option for cognitive dysfunction in various patient populations.
Check Digit Verification of cas no
The CAS Registry Mumber 1026134-63-3 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,2,6,1,3 and 4 respectively; the second part has 2 digits, 6 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 1026134-63:
(9*1)+(8*0)+(7*2)+(6*6)+(5*1)+(4*3)+(3*4)+(2*6)+(1*3)=103
103 % 10 = 3
So 1026134-63-3 is a valid CAS Registry Number.
1026134-63-3Relevant articles and documents
AZAADAMANTANE DERIVATIVES AND METHODS OF USE
-
Page/Page column 62; 97, (2008/12/06)
The invention relates to compounds that are azaadamantane derivatives, particularly ether- or amine-substituted azaadamantane derivatives and salts and prodrugs thereof, compositions comprising such compounds, methods of using such compounds and compositi
